MONEY

Inhibikase Therapeutics director Bellini acquires $2m in stock

Tomas Kauer - ModeratorTomas Kauer - Moderator
Oct 24, 2024 - 08:00
Inhibikase Therapeutics director Bellini acquires $2m in stock
Read More

Tags:

Previous Article

106 Questions You Can Ask Your Data with AI Chat 

Next Article

Mother sues AI chatbot company Character.AI, Google over son's suicide

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Tomas Kauer - Moderator
Tomas Kauer - Moderator

Related Posts

BKTI stock soars to 52-week high, touches $23.02 amid robust gains

BKTI stock soars to 52-week high, touches $23.02 amid r...

Tomas Kauer - Mode... Sep 25, 2024

New York Mayor Adams charged in Turkey bribery, fraud scheme

New York Mayor Adams charged in Turkey bribery, fraud s...

Tomas Kauer - Mode... Sep 27, 2024

Nuclear power renaissance on the way: UBS

Nuclear power renaissance on the way: UBS

Tomas Kauer - Mode... Sep 28, 2024